Localized Scleroderma (Morphea) Following Tick-Borne Encephalitis Vaccination in a Patient with Persistent Borrelia Infection: Histological–clinical Correlation
SN Comprehensive Clinical Medicine · 15.09.2026 · 8 (1)
DOI: 10.1007/s42399-026-02670-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 15.09.2026. Verfasst von Marta Kaķe und 4 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Introduction
We report a rare case of biopsy-proven localized scleroderma (morphea) that developed 14 days after the second dose of the tick-borne encephalitis vaccine (TICOVAC^®) in a 67-year-old woman with a history of prior erythema migrans and persistent Borrelia burgdorferi seropositivity. Important Clinical Findings The patient presented with progressive hypopigmented, firm, atrophic plaques involving the back, upper extremities, and trunk. Clinical examination and dermoscopy were consistent with morphea, and histopathological findings showed epidermal atrophy, hyperkeratosis, interstitial edema, and focal dermal sclerosis with a linear lymphocytic infiltrate. Autoimmune testing revealed elevated antinuclear and anti–double-stranded-DNA antibodies without systemic involvement. Persistent Borrelia burgdorferi IgG suggested prior infection. The Main Diagnoses, Therapeutic Interventions, and Outcomes Based on clinicopathologic correlation, a diagnosis of generalized morphea was established. The patient was treated with topical corticosteroids and calcineurin inhibitors along with systemic methotrexate, with early signs of disease stabilization.
Conclusion
Temporal association with vaccination raises the possibility that vaccine-related immune activation in the context of preexisting immune dysregulation and prior infection may have contributed to disease onset. Although causality cannot be confirmed, this case underscores the importance of evaluating cutaneous changes following immune stimulation, particularly in patients with autoimmune serologic abnormalities and prior tick-borne exposures, to enhance recognition of rare post-vaccination autoimmune reactions.
Zitieren
APA
Kaķe, M., Bondare-Ansberga, V., Mikažāns, I., Ščerbuks, M., & Zītare, E. (2026). Localized Scleroderma (Morphea) Following Tick-Borne Encephalitis Vaccination in a Patient with Persistent Borrelia Infection: Histological–clinical Correlation. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02670-8
Vancouver
Kaķe M, Bondare-Ansberga V, Mikažāns I, Ščerbuks M, Zītare E. Localized Scleroderma (Morphea) Following Tick-Borne Encephalitis Vaccination in a Patient with Persistent Borrelia Infection: Histological–clinical Correlation. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02670-8
BibTeX
@article{Kae2026,
author = {Kaķe, Marta and Bondare-Ansberga, Vanda and Mikažāns, Ingmārs and Ščerbuks, Mihails and Zītare, Evija},
title = {Localized Scleroderma (Morphea) Following Tick-Borne Encephalitis Vaccination in a Patient with Persistent Borrelia Infection: Histological–clinical Correlation},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02670-8}
}
EUVIMED